¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

ºÐ´ç¼­¿ï´ëº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 15Â÷ ÀÎõ.°æ±âÁöȸ Çмú´ëȸ : 2018-12-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
ºÐ´ç¼­¿ï´ëº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 15Â÷ ÀÎõ.°æ±âÁöȸ Çмú´ëȸ : 2018-12-22
±³À°ÀÏÀÚ : 2018-12-22
±³À°Àå¼Ò : ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç  
±³À°ÁÖÁ¦ : 2018 Á¦ 15Â÷ ÀÎõ.°æ±âÁöȸ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢±â°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÀÎõ°æ±âÁöȸ  
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-582-8572  
À̸ÞÀÏ : app@app2010.com      
±³À°Á¾·ù : ºñ´¢±â°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 4 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 12:20~12:35 How to minimize the risk of infection during prostate biopsy  ¹è»ó¶ô(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 12:35~12:50 Focal therapy: is it really good?  ÀÌÇйÎ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 12:50~13:05 Is cytoreductive prostatectomy really beneficial?  ±è±¤ÅÃ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 13:05~13:20 Longterm outcomes after bladder-preserving tri-modal therapy versus radical cystectomy in muscle-invasive bladder cancer  ½É¸í¼±(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 13:20~13:35 Combination pills in urology; do we really need them?  À̽¿í(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 13:35~13:50 TRT for non-hypogonadal men  ¿Àö¿µ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 13:50~14:05 Management of varicocele 2018  Á¶¼º¿ë(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 14:05~14:20 Nocturia in aging male: association with testosterone  ÃÖ¿ë¼±(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 14:40~14:55 How to manage problems during HOLEP  ÇѺ´±Ô(ÆÛÆåÆ®ºñ´¢±â°ú) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 14:55~15:10 How to manage ureteral avulsion during ureteroscopy  Á¶¼®(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 15:10~15:25 How to manage problems during laparoscopic/robotic kidney surgery  ±èÈñ¿¬(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 15:25~15:40 Urethral stricture: immediate vs delayed intervention  À̽·ü(CHAÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 15:40~15:55 Optimal management of biochemical recurrence after radical prostatectomy  Å¹ü½Ä(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 15:55~16:10 Cytoreductive surgery in metastatic kidney cancer  ÀÌ»ó¿í(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 16:10~16:25 How to manage urine leakage after radical cystectomy  ±èÇü¼®(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 16:25~16:35 Optimal treatment of metastatic bladder cancer  ¼­È£°æ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 16:35~16:50 Current status of combination medication for OAB symptoms  Á¤¼ºÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 16:50~17:05 Complicated urinary dysfunction after prostate cancer treatment  ±èÅÂÇå(CHAÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 17:05~17:20 Complications of SUI & pelvic prolapse surgery  ÀÌ°Çö(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 12-22 ºÐ´ç¼­¿ï´ëº´¿ø ´ë°­´ç 17:20~17:35 BPH surgery: endoscopic enucleation  À̵¿¼·(°¡Å縯ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ºÐ´ç¼­¿ï´ëº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 15Â÷ ÀÎõ.°æ±âÁöȸ Çмú´ëȸ : 2018-12-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2018³â 12¿ù ´ëÇÑÄ¡¸ÅÇÐȸ ½ÉÆ÷Áö¿ò : 2018-12-22
´ÙÀ½±Û ÀÎÁ¦´ëÇб³ºÎ»ê¹éº´¿ø Á¦17ȸ ¹éÀÎÁ¦±â³äÀÓ»óÀÇÇבּ¸¼Ò Çмú´ëȸ : 2018-12-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20889 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 121 2024-05-27
20888 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 35 2024-05-27
20887 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 23 2024-05-27
20886 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 26 2024-05-27
20885 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 45 2024-05-27
20884 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 14 2024-05-27
20883 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 22 2024-05-27
20882 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 13 2024-05-27
20881 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 19 2024-05-27
20880 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 22 2024-05-27
20879 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 21 2024-05-27
20878 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 21 2024-05-27
20877 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 14 2024-05-27
20876 ¼­¿ï 2024³â ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ Á¦3ȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 13 2024-05-27
20875 ¼­¿ï °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸ ILD School 202 : 2024-06-29 0 10 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷